Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. Iloprost may be effective in preventing lung cancer.
PURPOSE: This randomized phase II trial is studying how well iloprost works in preventing
lung cancer in patients who are at high risk for this disease.